| RS74315474 |
ARSA
|
Health Risk |
Pathogenic |
METACHROMATIC LEUKODYSTROPHY, SEVERE |
| RS74315475 |
ARSA
|
Health Risk |
Pathogenic |
METACHROMATIC LEUKODYSTROPHY, SEVERE |
| RS74315476 |
ARSA
|
Health Risk |
Pathogenic |
METACHROMATIC LEUKODYSTROPHY, SEVERE |
| RS74315477 |
ARSA
|
Health Risk |
Pathogenic/Likely pathogenic |
METACHROMATIC LEUKODYSTROPHY, MILD |
| RS74315478 |
ARSA
|
Health Risk |
Likely pathogenic |
ARYLSULFATASE A PSEUDODEFICIENCY, SEVERE |
| RS74315479 |
ARSA
|
Health Risk |
Pathogenic/Likely pathogenic |
ARYLSULFATASE A PSEUDODEFICIENCY, INTERMEDIATE |
| RS74315480 |
ARSA
|
Health Risk |
Likely pathogenic |
Metachromatic leukodystrophy, Metachromatic leukodystrophy |
| RS74315481 |
ARSA
|
Health Risk |
Pathogenic/Likely pathogenic |
METACHROMATIC LEUKODYSTROPHY, MILD |
| RS74315482 |
ARSA
|
Health Risk |
Pathogenic |
ARYLSULFATASE A PSEUDODEFICIENCY, ARYLSULFATASE A PSEUDODEFICIENCY |
| RS74315483 |
ARSA
|
Health Risk |
Pathogenic |
Metachromatic leukodystrophy, late infantile form |
| RS74315484 |
ARSA
|
Health Risk |
Pathogenic |
Metachromatic leukodystrophy, late infantile form |
| RS74315485 |
ARSA
|
Health Risk |
Conflicting classifications of pathogenicity |
Metachromatic leukodystrophy, juvenile type |
| RS74315486 |
CRYBA4
|
Health Risk |
Pathogenic |
Cataract 23, Cataract 23 |
| RS74315487 |
CRYBA4
|
Health Risk |
Pathogenic |
Cataract 23, Cataract 23 |
| RS74315488 |
CRYBB1
|
Health Risk |
Pathogenic |
Cataract 17 multiple types, Cataract 17 multiple types |
| RS74315489 |
CRYBB2
|
Health Risk |
Pathogenic |
Cataract 3 multiple types, Developmental cataract |
| RS74315490 |
CRYBB3
|
Health Risk |
Pathogenic |
Developmental cataract, Cataract 22 multiple types |
| RS74315492 |
NF2
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 2 |
| RS74315493 |
NF2
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 2 |
| RS74315494 |
NF2
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 2 |
| RS74315495 |
NF2
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 2 |
| RS74315496 |
NF2
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 2 |
| RS74315497 |
NF2
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 2 |
| RS74315498 |
NF2
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 2 |
| RS74315499 |
NF2
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 2 |
| RS74315500 |
NF2
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS74315501 |
NF2
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 2 |
| RS74315503 |
NF2
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 2 |
| RS74315504 |
NF2
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 2 |
| RS74315505 |
NF2
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 2 |
| RS74315506 |
PEX26
|
Health Risk |
Pathogenic/Likely pathogenic |
Peroxisome biogenesis disorder 7B, Peroxisome biogenesis disorder 7A (Zellweger) |
| RS74315507 |
RAC2
|
Health Risk |
Pathogenic |
Neutrophil immunodeficiency syndrome, Neutrophil immunodeficiency syndrome |
| RS74315508 |
RTN4R
|
Health Risk |
risk factor |
Schizophrenia, susceptibility to |
| RS74315509 |
RTN4R
|
Health Risk |
risk factor |
Schizophrenia, susceptibility to |
| RS74315510 |
SCO2
|
Health Risk |
Pathogenic |
Cardioencephalomyopathy, fatal infantile |
| RS74315511 |
SCO2
|
Health Risk |
Pathogenic |
Cardioencephalomyopathy, fatal infantile |
| RS74315512 |
SCO2
|
Health Risk |
Pathogenic/Likely pathogenic |
Cardioencephalomyopathy, fatal infantile |
| RS74315513 |
SMARCB1
|
Health Risk |
Pathogenic |
SMARCB1-related schwannomatosis, Hereditary cancer-predisposing syndrome |
| RS74315514 |
SOX10
|
Health Risk |
Pathogenic |
Waardenburg syndrome type 4C, Waardenburg syndrome type 4C |
| RS74315515 |
SOX10
|
Health Risk |
Pathogenic/Likely pathogenic |
Waardenburg syndrome type 2E, without neurologic involvement |
| RS74315516 |
SOX10
|
Health Risk |
Pathogenic |
PCWH syndrome, PCWH syndrome |
| RS74315518 |
SOX10
|
Health Risk |
Pathogenic |
PCWH syndrome, PCWH syndrome |
| RS74315520 |
SOX10
|
Health Risk |
Pathogenic |
Waardenburg syndrome type 4C, Waardenburg syndrome type 2E |
| RS74315521 |
SOX10
|
Health Risk |
Pathogenic |
PCWH syndrome, PCWH syndrome |
| RS74315522 |
TBX1
|
Health Risk |
Pathogenic |
Velocardiofacial syndrome, Velocardiofacial syndrome |
| RS74316682 |
POR
|
Health Risk |
Likely pathogenic |
Congenital adrenal hyperplasia due to cytochrome P450 oxidoreductase deficiency, Congenital adrenal hyperplasia due to cytochrome P450 oxidoreductase deficiency |
| RS74317435 |
DNAH7
|
Health Risk |
Conflicting classifications of pathogenicity |
DNAH7-related disorder, DNAH7-related disorder |
| RS74323799 |
CFHR5
|
Health Risk |
Conflicting classifications of pathogenicity |
CFH-Related Dense Deposit Disease / Membranoproliferative Glomerulonephritis Type II, CFH-Related Dense Deposit Disease / Membranoproliferative Glomerulonephritis Type II |
| RS74323945 |
SLC2A1
|
Health Risk |
Conflicting classifications of pathogenicity |
GLUT1 deficiency syndrome 1, autosomal recessive |
| RS74324101 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive limb-girdle muscular dystrophy type 2J, Dilated cardiomyopathy 1G |
| RS74339310 |
LRRCC1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS74339576 |
KCNJ11
|
Health Risk |
Conflicting classifications of pathogenicity |
Hyperinsulinemic hypoglycemia, familial |
| RS74341575 |
CHRNA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal dominant nocturnal frontal lobe epilepsy, Autosomal dominant nocturnal frontal lobe epilepsy 4 |
| RS74346519 |
MEFV
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial Mediterranean fever, MEFV-related disorder |
| RS743546 |
FLNA
|
Health Risk |
Conflicting classifications of pathogenicity |
Intestinal pseudoobstruction, neuronal |
| RS74358901 |
ABCG8
|
Health Risk |
Conflicting classifications of pathogenicity |
Sitosterolemia 1, Cardiovascular phenotype |
| RS74360232 |
SLC17A5
|
Health Risk |
Conflicting classifications of pathogenicity |
Salla disease, Sialic acid storage disease |
| RS74360487 |
ALK
|
Health Risk |
Conflicting classifications of pathogenicity |
Neuroblastoma, susceptibility to |
| RS74363455 |
TSC2
|
Health Risk |
Pathogenic |
— |
| RS74374973 |
POMGNT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive limb-girdle muscular dystrophy type 2O, Muscle eye brain disease |
| RS74375534 |
KMT2E
|
Health Risk |
Conflicting classifications of pathogenicity |
O'Donnell-Luria-Rodan syndrome, See cases |
| RS7437875 |
CFI
|
Health Risk |
Conflicting classifications of pathogenicity |
Atypical hemolytic-uremic syndrome with I factor anomaly, Atypical hemolytic-uremic syndrome |
| RS74382477 |
POLG
|
Health Risk |
Conflicting classifications of pathogenicity |
Progressive sclerosing poliodystrophy, Hereditary spastic paraplegia |
| RS74384554 |
LTBP2
|
Health Risk |
Conflicting classifications of pathogenicity |
Glaucoma 3, primary congenital |
| RS74385826 |
WDR35
|
Health Risk |
Conflicting classifications of pathogenicity |
Cranioectodermal dysplasia 2, Short-rib thoracic dysplasia 7 with or without polydactyly |
| RS74396541 |
MLH1
|
Health Risk |
Pathogenic |
Hereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome |
| RS74405673 |
FH
|
Health Risk |
Conflicting classifications of pathogenicity |
Fumarase deficiency, Hereditary leiomyomatosis and renal cell cancer |
| RS74406856 |
MYH3
|
Health Risk |
Conflicting classifications of pathogenicity |
Distal arthrogryposis type 2B1, Freeman-Sheldon syndrome |
| RS74407840 |
PLIN1
|
Health Risk |
Conflicting classifications of pathogenicity |
PLIN1-related familial partial lipodystrophy, Monogenic diabetes |
| RS74411086 |
PDE6B
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinal dystrophy, Inborn genetic diseases |
| RS74414989 |
ATP8B1
|
Health Risk |
Pathogenic |
— |
| RS74419361 |
EYS
|
Health Risk |
Pathogenic |
Retinitis pigmentosa, Retinitis pigmentosa 25 |
| RS7442295 |
SLC2A9
|
Health Risk |
association |
Uric acid concentration, serum |
| RS74423119 |
DYSF
|
Health Risk |
Conflicting classifications of pathogenicity |
Neuromuscular disease caused by qualitative or quantitative defects of dysferlin, Autosomal recessive limb-girdle muscular dystrophy type 2B |
| RS74424227 |
KCNE2
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital long QT syndrome, Cardiovascular phenotype |
| RS74426960 |
WASHC4
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS74428123 |
HADH
|
Health Risk |
Conflicting classifications of pathogenicity |
Deficiency of 3-hydroxyacyl-CoA dehydrogenase, Hyperinsulinemic hypoglycemia |
| RS74429712 |
GABBR2
|
Health Risk |
Conflicting classifications of pathogenicity |
Epileptic encephalopathy, Neurodevelopmental disorder with poor language and loss of hand skills |
| RS74435397 |
EMG1
|
Health Risk |
Pathogenic |
Bowen-Conradi syndrome, Bowen-Conradi syndrome |
| RS74438152 |
ELP2
|
Health Risk |
Conflicting classifications of pathogenicity |
ELP2-related disorder, ELP2-related disorder |
| RS74451194 |
ERMARD
|
Health Risk |
Conflicting classifications of pathogenicity |
ERMARD-related disorder, ERMARD-related disorder |
| RS74452732 |
GNRHR
|
Health Risk |
Pathogenic |
Hypogonadotropic hypogonadism 7 with or without anosmia, Hypogonadotropic hypogonadism 7 with or without anosmia |
| RS74458693 |
ITGB3
|
Health Risk |
Likely pathogenic |
Glanzmann thrombasthenia, Cervical cancer |
| RS74461100 |
TULP1
|
Health Risk |
Pathogenic |
TULP1-related disorder, Retinal dystrophy |
| RS74461721 |
PLEC
|
Health Risk |
Conflicting classifications of pathogenicity |
Epidermolysis bullosa simplex 5C, with pyloric atresia |
| RS74462309 |
KCNQ1
|
Health Risk |
Likely pathogenic |
Congenital long QT syndrome, Long QT syndrome |
| RS74462743 |
GBA1
|
Health Risk |
Pathogenic |
— |
| RS74463786 |
SYNE1
|
Health Risk |
Conflicting classifications of pathogenicity |
Emery-Dreifuss muscular dystrophy 4, autosomal dominant |
| RS74467662 |
CFTR
|
Health Risk |
Pathogenic |
Cystic fibrosis, Congenital bilateral aplasia of vas deferens from CFTR mutation |
| RS74469870 |
KIF1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary spastic paraplegia 30, Neuropathy |
| RS74470618 |
WDR35
|
Health Risk |
Conflicting classifications of pathogenicity |
Short-rib thoracic dysplasia 7 with or without polydactyly, Cranioectodermal dysplasia 2 |
| RS74475415 |
ITGA2B
|
Health Risk |
Pathogenic |
Glanzmann thrombasthenia, Glanzmann thrombasthenia 1 |
| RS74482326 |
NEB
|
Health Risk |
Conflicting classifications of pathogenicity |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS74485751 |
VPS13B
|
Health Risk |
Pathogenic |
Cohen syndrome, Cohen syndrome |
| RS74486266 |
BMP4
|
Health Risk |
Conflicting classifications of pathogenicity |
Microphthalmia with brain and digit anomalies, Orofacial cleft 11 |
| RS74486803 |
PAH
|
Health Risk |
Pathogenic |
Hyperphenylalaninemia, Phenylketonuria |
| RS74495140 |
BMP4
|
Health Risk |
Conflicting classifications of pathogenicity |
Orofacial cleft 11, Orofacial cleft 11 |
| RS74499808 |
SETBP1
|
Health Risk |
Pathogenic/Likely pathogenic |
Schinzel-Giedion syndrome, SETBP1-related disorder |
| RS74500255 |
GBA1
|
Health Risk |
Pathogenic/Likely pathogenic |
Gaucher disease type I, Gaucher disease-ophthalmoplegia-cardiovascular calcification syndrome |
| RS74503222 |
PAH
|
Health Risk |
Pathogenic |
Phenylketonuria, Phenylketonuria |